Pharmacy Dropshipping Services

Medicine Suppliers, Send Medicines to abroad

Guarantee delivery to the USA, UK, AU, China, Hong Kong, New Zeland via Express (EMS) or Registered Mail (RMS). We work only by request form, please fill request form for receive the prices of needed medication, or making the order.

We offer special delivery services for the customers who has prescription, we can ship to any country to which we can not ship via normal shipping methods (Canada, Germany, Italy, Sweden, Netherlands), as like RMS or EMS, we can ship via DHL.

We have all the licenses required for delivering drugs and registered with the relevant government agencies, such as drugs, the controller, the import of the Export Department, the sales tax department, pharmacist license in India, medicine wholesale license.

Description about India Market
Even more billions are saved when hospitals use generics. A generic drug is the same as a brand-name drug in dosage, safety, strength, quality, the way it works, the way it is taken and the way it should be used. A generic drug is identical  or bioequivalent  to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Although generic drugs are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price. Another driver of India’s pharmaceutical sector is the potentially lucrative biosimilars market, which is expected to increase to $40 billion globally by 2020, as biologic treatments are introduced for diseases such as diabetes, cancer, multiple sclerosis, and rheumatoid arthritis. The pharmaceuticals market in India, valued at $20 billion in 2015, is set to soar to $55 billion by 2020, representing an impressive Compound Annual Growth Rate (CAGR) of 22.4%, says research and consulting firm GlobalData. According to the company’s latest report, India’s rapidly growing generics market is the primary driver of the nation’s pharmaceutical sector, with sales expected to soar by nearly 84% to $26.1 billion in 2016. Generic drugs, with their low costs and easy accessibility, now dominate India’s pharmaceutical space, accounting for around 70% of the market. Generic drugs, with their low costs and easy accessibility, now dominate India’s pharmaceutical space, accounting for around 70% of the market.